Hypoglycaemia: Intramuscular and intravenous glucagon were similar in effect

Clinical bottom line (level 2b-)

  1. In patients with hypoglycaemic coma, intramuscular and intravenous glucagon appeared similar in their ability to rouse.
MacCuish et al: Lancet 1970; 1: 946-949
Expires August 2003

The study

Single-blinded ?concealed quasi-randomised trial with intention-to-treat
Setting: diabetic or accident and emergency department of one hospital, UK

100 patients (aged range 20 to 40 years, ?% male) diabetics brought by ambulance or car at the request of a doctor, relative, friend or police, with suspected hypoglycaemia
Control Group: (n = 50, 50 analysed): intravenous glucagon 1mg
Experimental Group: (n = 50, 50 analysed): intramuscular glucagon

100% followed for 60 minutes

The evidence

Outcome Time to outcome CEREERRRR
(95% CI)
ARR
(95% CI)
NNT
(95% CI)
recovery in <0 mins 30 minutes 32
(64%)
27
(54%)
16%
(-17% to 39%)
10%
(-9% to 29%)
10
(NNT = 3 to infinity;
NNH = 11 to infinity)

Comments

  1. No details of randomisation given; from exact 50/50 split and the decision to enter 100 patients it may be reasonable to assume it's alternate allocation
  2. 'Recovery' included ability to take oral glucose; may vary from other definitions

Citation

  1. MacCuish AC, Munro JF, Duncan LJP: Treatment of hypoglycaemic coma with glucagon, intravenous dextrose, and mannitol infusion in a hundred diabetics. Lancet 1970; 1: 946-949
Contributor: Bob Phillips and Clare Wotton, August 1999
Reviewer:

Clinical Question.
Patient in patients with hypoglycaemia and altered mental status
Intervention or Exposure intravenous glucagon
Comparison intramuscular glucagon
Outcome speed of recovery or requirement for further treatment